Allosteric PI3K-alpha inhibition overcomes on-target resistance to orthosteric inhibitors mediated by secondary PIK3CA mutations. Varkaris, A., Fece de la Cruz, F., Martin, E. E, Norden, B. L, Chevalier, N., Kehlmann, A. M, Leshchiner, I., Barnes, H., Ehnstrom, S., Stavridi, A., & others Cancer Discovery, American Association for Cancer Research, 2023.
bibtex   
@article{varkaris2023allosteric,
  title={Allosteric PI3K-alpha inhibition overcomes on-target resistance to orthosteric inhibitors mediated by secondary PIK3CA mutations.},
  author={Varkaris, Andreas and Fece de la Cruz, Ferran and Martin, Elizabeth E and Norden, Bryanna L and Chevalier, Nicholas and Kehlmann, Allison M and Leshchiner, Ignaty and Barnes, Haley and Ehnstrom, Sara and Stavridi, Anastasia-Maria and others},
  journal={Cancer Discovery},
  year={2023},
  publisher={American Association for Cancer Research}
}

Downloads: 0